MUSTANG BIO, INC. Gain (Loss) on Termination of Lease
MUSTANG BIO, INC. (MBIO) reported Gain (Loss) on Termination of Lease of $400.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-08-05
- MUSTANG BIO, INC. gain (loss) on termination of lease for the quarter ending 2026-03-31 was $400.00K, a 1.52% increase year-over-year.
- MUSTANG BIO, INC. gain (loss) on termination of lease for the quarter ending 2025-03-31 was $394.00K.
- MUSTANG BIO, INC. gain (loss) on termination of lease for fiscal 2025 was $394.00K, a 25.48% increase from fiscal 2024.
- MUSTANG BIO, INC. gain (loss) on termination of lease for fiscal 2024 was $314.00K.
| Period end | Gain (Loss) on Termination of Lease | Gain (Loss) on Termination of Lease 1 month | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-08-05 | |||||
| 2026-03-31 | $400.00K 10-Q · filed 2026-05-05 | |||||
| 2025-12-31 | $394.00K 10-K · filed 2026-03-19 | |||||
| 2025-09-30 | $394.00K 10-Q · filed 2025-11-07 | |||||
| 2025-06-30 | $394.00K 10-Q · filed 2025-08-08 | |||||
| 2025-03-31 | $394.00K 10-Q · filed 2025-05-14 | |||||
| 2025-02-28 | $400.00K 10-K · filed 2026-03-19 | |||||
| 2024-12-31 | $314.00K 10-K · filed 2026-03-19 | |||||
| 2024-09-30 | $314.00K 10-Q · filed 2025-11-07 | |||||
| 2024-06-30 | $314.00K 10-Q · filed 2025-08-08 | |||||
| 2024-06-28 | $40.00K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |